Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
AssigneeThe Kennedy Institute of Rheumatology
InventorsMichael J. Elliott, Ravinder N. Maini, Marc Feldmann
Life of this patent
Estimating the term…
Abstract
A method of treating or preventing a cardiovascular and/or a cerebrovascular disorder in an individual is disclosed. Also disclosed is a method for treating and/or preventing a thrombotic disorder in an individual. Further disclosed is a method of decreasing plasma fibrinogen in an individual.
Claims1
A method of treating a thrombotic disorder in an individual in need thereof comprising administering a therapeutically effective amount of an anti-human tumor necrosis factor-α monoclonal antibody or antigen-binding fragment thereof to the individual, wherein the thrombotic disorder is deep vein thrombosis.
Dependencies are inferred from the claim text.